Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial safety of Vagifem Low Dose in postmenopausal women with atrophic vaginitis
2006-001629-24Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2006
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of estradiol in atrophic vaginitis, sponsored by Novo Nordisk. Primary endpoint: Endometrial hyperplasia rate at 12 months. Started Sep 2006; status: completed.
02
Drugs
estradiol
03
Conditions
atrophic vaginitis
Beyond the preview
Go deeper on 2006-001629-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001629-24.